Key facts
- Innovodigm’s last known valuation is $3.7M (Jun 2025).
- It has raised $640K; the latest was Seed Round ($640K) in Jun 2025.
- Notable investors include Indian Angel Network, IKP Knowledge Park, Padup Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Innovodigm
- ·The full record, as it builds
Funding rounds
No funding rounds for Innovodigm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Innovodigm
Developer of a microneedle-based platform technology designed for effective, transdermal vaccine and biologics delivery. The company is developing a thermostable vaccine delivery patch created in a way require any cold chain infrastructure and no need for trained healthcare professionals to administer the vaccines, enabling healthcare sector and patients to have vaccines more accessible to the remotest corners where vaccines cannot reach due to a lack of proper infrastructure and trained healthcare professionals.
- Sector
- Healthcare
- HQ
- Kolkata, India
- Founded
- 2020
- Employees
- 5
- Website
- innovodigm.com/
- Ownership
- Privately Held (backing)
Innovodigm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innovodigm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innovodigm in its N-PORT filings yet. We sweep new filings monthly.